News NHS could pay more for medicines under new plan Changes to the threshold used by NICE to measure cost-effectiveness could be on the way as part of a plan that would raise NHS spending on medicines.
News Pharma tariffs yet to emerge as Trump seeks more deals Donald Trump looks set to delay the introduction of his tariffs on pharma imports in order to negotiate more deals with drugmakers on drug pricing.
News Trump, Pfizer announce MFN deal; Lilly, others to come At the White House today, President Trump and Pfizer CEO Albert Bourla announced the first of many deals to secure MFN drug prices for US consumers.
News AbbVie joins BMS in taking a hard line on UK drug pricing AbbVie has said it may not launch its ovarian cancer therapy Elahere in the UK if a viable NHS price cannot be agreed with NICE.
News PhRMA unveils DTC sales site, as more drugmakers join in Pharma is embracing DTC selling of medicines in the US, and industry body PhRMA has stepped in to help cut out the middlemen in the supply chain.
News AstraZeneca hops on the DTC sales train in the US AstraZeneca has become the latest pharma group to set up a direct-to-consumer sales channel in the US, covering Farxiga, Airsupra, and FluMist.
News FDA points to liver injury with Amgen's Tavneos The FDA has raised the pressure on Amgen to withdraw vasculitis drug Tavneos from the market with a report linking serious side effects to the drug.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.